skip navigation
National Criminal Justice Reference Service
Login | Subscribe/Register | Manage Account | Shopping Cartshopping cart icon | Help | Contact Us | Home     
National Criminal Justice Reference Service
  Advanced Search
Search Help
     
| | | | |
place holder
Administered by the Office of Justice Programs U.S. Department of Justice Office of Justice Programs Seal National Criminal Justice Reference Service National Criminal Justice Reference Service Office of Justice Programs Seal National Criminal Justice Reference Service
Topics
A-Z Topics
Corrections
Courts
Crime
Crime Prevention
Drugs
Justice System
Juvenile Justice
Law Enforcement
Victims
Left Nav Bottom Line
Home / NCJRS Abstract

Publications
 

NCJRS Abstract


The document referenced below is part of the NCJRS Library collection.
To conduct further searches of the collection, visit the NCJRS Abstracts Database.

How to Obtain Documents
 
NCJ Number: NCJ 061557  
Title: MEDICARE AND MEDICAID FRAUDS, PART 4 - HEARING BEFORE THE SENATE SUBCOMMITTEE ON LONG-TERM CARE, 94TH CONGRESS, 2ND SESSION, FEBRUARY 16, 1976
Author(s): ANON
Corporate Author: US Congress
Senate Special Cmtte on Aging
United States
Sale: Superintendent of Documents, GPO
Washington, DC 20402
United States

National Institute of Justice/
NCJRS paper reproduction
Box 6000, Dept F
Rockville, MD 20849
United States
Publication Date: 1976
Pages: 112
Type: Legislative/regulatory materials
Origin: United States
Language: English
Note: ISSUED IN 9 PARTS.
Annotation: FRAUD AND ABUSE BY CLINICAL LABORATORIES WERE EXAMINED IN THE FOURTH SESSION OF THE 1976 SENATE COMMITTEE HEARINGS ON MEDICARE AND MEDICAID FRAUD. TESTIMONY FOCUSED ON INVESTIGATIONS IN ILLINIOIS AND NEW JERSEY.
Abstract: SENATOR MOSS SUMMARIZED THE MOST COMMON ABUSES OF MEDICAID PAYMENTS BY CLINICAL LABORATORIES AS FOLLOWS: PERFORMING ADDITIONAL TESTS NOT ORDERED BY A DOCTOR, CLAIMING LAB TESTS WERE PERFORMED MANUALLY WHEN THEY WERE ACTUALLY COMPLETED BY MACHINE, BILLING TWICE FOR THE SAME SERVICE BY FALSIFYING DATES, AND REPORTING PROCEDURES AS COMPLETED WHEN A CLINIC WAS UNABLE TO PERFORM THE TEST. AFTER OPENING STATEMENTS BY SEVERAL SENATORS, THE ASSOCIATE COUNSEL FOR THE COMMITTEE ON THE AGING TESTIFIED ON THE INVESTIGATIONS INTO CLINICAL LABORATORY FRAUD IN ILLINOIS, NEW JERSEY, CALIFORNIA, PENNSYLVANIA, AND NEW YORK THAT THE COMMITTEE STAFF HAD UNDERTAKEN. THEIR REPORT CONCLUDED THAT A SMALL NUMBER OF CLINICAL LABORATORIES CONTROLLED MOST MEDICAID BUSINESS AND THAT KICKBACKS TO PHYSICIANS OR CLINIC OWNERS WERE WIDESPREAD. THE WITNESS STATED THAT MEDICAID FEE SCHEDULES ESTABLISHED IN 1967 WERE OVERGENEROUS BECAUSE TECHNOLOGICAL ADVANCES HAD REDUCED THE TIME AND LABOR NECESSARY FOR MANY TESTS. INVESTIGATORS FROM THE BETTER GOVERNMENT ASSOCIATION IN CHICAGO DESCRIBED THEIR INVESTIGATIONS OF KICKBACKS OFFERED BY LABORATORIES TO CLINICS SPECIALIZING IN MEDICAID PATIENTS. THE EXECUTIVE DIRECTOR OF THE NEW JERSEY COMMISSION OF INVESTIGATION TESTIFIED ON PIONEER INVESTIGATIONS OF FRAUD BY CLINICAL LABORATORIES WHICH UNCOVERED KICKBACKS, REBATES, AND INSTANCES OF DOCTORS HAVING PARTIAL OWNERSHIP IN LABORATORIES. THE WITNESS RECOMMENDED SUBSTANTIAL REDUCTIONS IN SCHEDULED LAB FEES TO ELIMINATE CLINICS' OPPORTUNITIES FOR WINDFALL PROFITS. THE APPENDIX CONTAINS A RANDOM SELECTION OF LABORATORY BILLS WHICH ILLUSTRATE FRAUDULENT PRACTICES, AFFIDAVITS BY INVESTIGATORS FOR THE BETTER GOVERNMENT ASSOCIATION, AND LETTERS FROM THE PRESIDENT OF THE COLLEGE OF AMERICAN PATHOLOGISTS AND TWO NEW JERSEY STATE OFFICIALS. (MJM)
Index Term(s): Medical costs ; Fraud ; Medicare or Medicaid abuse ; Kickbacks ; Illinois ; New Jersey
 
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/Publications/abstract.aspx?ID=61557

* A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's web site is provided.


Contact Us | Feedback | Site Map
Freedom of Information Act | Privacy Statement | Legal Policies and Disclaimers | USA.gov

U.S. Department of Justice | Office of Justice Programs | Office of National Drug Control Policy

place holder